{"transactions":[{"id":2682801,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":138695,"kind":"person","name":"MAROON JOSEPH C MD","position":1,"cik":"0001221600","reported_name":"MAROON JOSEPH C MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-03T17:00:45.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is durational-based. All 275,000 option shares vest and become exercisable on April 15, 2022, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service."}],"balance_after":275000,"derivative":{"exercise_price":0.39,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001510964-21-000038","document":"wf-form4_162275399709514.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1221600/000151096421000038/wf-form4_162275399709514.xml","form_type":"4"}},{"id":2698516,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":138695,"kind":"person","name":"MAROON JOSEPH C MD","position":1,"cik":"0001221600","reported_name":"MAROON JOSEPH C MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-24T16:59:31.000Z","date":"2021-05-21","kind":"purchase","acquired":true,"shares":50000,"price":0.38,"value":19000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple transactions, each at a price of $0.38 per share."}],"balance_after":791116,"source":{"system":"sec-edgar","filing":"0001510964-21-000030","document":"wf-form4_162188994877451.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1221600/000151096421000030/wf-form4_162188994877451.xml","form_type":"4"}},{"id":3105226,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":138695,"kind":"person","name":"MAROON JOSEPH C MD","position":1,"cik":"0001221600","reported_name":"MAROON JOSEPH C MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-18T20:48:36.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is durational-based. 40,000 option shares vested on the date of grant and the remaining 150,000 option shares vest and become exercisable on June 16, 2021, provided, however, that there has not been a termination of service as of such date. In no event will the option become exercisable for any additional option shares after a termination of service."}],"balance_after":190000,"derivative":{"exercise_price":0.75,"expiration_date":"2030-06-15","underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001510964-20-000054","document":"wf-form4_159252769877664.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1221600/000151096420000054/wf-form4_159252769877664.xml","form_type":"4"}},{"id":3284261,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":138695,"kind":"person","name":"MAROON JOSEPH C MD","position":1,"cik":"0001221600","reported_name":"MAROON JOSEPH C MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-07T18:25:34.000Z","date":"2020-02-06","kind":"purchase","acquired":true,"shares":26000,"price":0.94,"value":24440.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were purchased in multiple transactions at price of $0.94 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person undertakes to provide CV Sciences, Inc., any security holder of CV Sciences, Inc., or the staff of the Securities and Exchange Commission, upon request, the full information regarding the number of shares purchased at each seperate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":741116,"source":{"system":"sec-edgar","filing":"0001510964-20-000002","document":"wf-form4_158111791665586.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1221600/000151096420000002/wf-form4_158111791665586.xml","form_type":"4"}},{"id":3332462,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":138695,"kind":"person","name":"MAROON JOSEPH C MD","position":1,"cik":"0001221600","reported_name":"MAROON JOSEPH C MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-23T19:15:29.000Z","date":"2019-12-11","kind":"purchase","acquired":true,"shares":46725,"price":1.09,"value":50930.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person undertakes to provide CV Sciences, Inc., any security holder of CV Sciences, Inc., or the staff of the Securities and Exchange Commission, upon request, the full information regarding the number of shares purchased at each seperate price within the ranges set forth in footnotes (1) and (2) to this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.07 to $1.09 per share, inclusive."}],"balance_after":715116,"source":{"system":"sec-edgar","filing":"0001510964-19-000079","document":"wf-form4_157714651123513.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1221600/000151096419000079/wf-form4_157714651123513.xml","form_type":"4"}},{"id":3332461,"issuer":{"id":8316,"kind":"organization","name":"CV Sciences, Inc.","symbol":"CVSI"},"owners":[{"id":138695,"kind":"person","name":"MAROON JOSEPH C MD","position":1,"cik":"0001221600","reported_name":"MAROON JOSEPH C MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-23T19:15:29.000Z","date":"2019-12-05","kind":"purchase","acquired":true,"shares":25000,"price":0.98,"value":24500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were purchased in multiple transactions at price of $0.98 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person undertakes to provide CV Sciences, Inc., any security holder of CV Sciences, Inc., or the staff of the Securities and Exchange Commission, upon request, the full information regarding the number of shares purchased at each seperate price within the ranges set forth in footnotes (1) and (2) to this Form 4."}],"balance_after":668391,"source":{"system":"sec-edgar","filing":"0001510964-19-000079","document":"wf-form4_157714651123513.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1221600/000151096419000079/wf-form4_157714651123513.xml","form_type":"4"}},{"id":4273354,"issuer":{"id":16217,"kind":"organization","name":"Mylan II B.V.","symbol":"MYL"},"owners":[{"id":138695,"kind":"person","name":"MAROON JOSEPH C MD","position":1,"cik":"0001221600","reported_name":"MAROON JOSEPH C MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-06-23T19:04:59.000Z","date":"2017-06-22","kind":"exercise","acquired":false,"shares":3653,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the right to receive one ordinary share of Mylan N.V. These RSUs vested in full on June 22, 2017 in connection with the conclusion of Dr. Maroon's service as a director on such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the right to receive one ordinary share of Mylan N.V. These RSUs vested in full on June 22, 2017 in connection with the conclusion of Dr. Maroon's service as a director on such date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":3653},"source":{"system":"sec-edgar","filing":"0000899243-17-017148","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1221600/000089924317017148/doc4.xml","form_type":"4"}},{"id":4273353,"issuer":{"id":16217,"kind":"organization","name":"Mylan II B.V.","symbol":"MYL"},"owners":[{"id":138695,"kind":"person","name":"MAROON JOSEPH C MD","position":1,"cik":"0001221600","reported_name":"MAROON JOSEPH C MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-06-23T19:04:59.000Z","date":"2017-06-22","kind":"exercise","acquired":true,"shares":3653,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":29256,"source":{"system":"sec-edgar","filing":"0000899243-17-017148","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1221600/000089924317017148/doc4.xml","form_type":"4"}},{"id":4396986,"issuer":{"id":16217,"kind":"organization","name":"Mylan II B.V.","symbol":"MYL"},"owners":[{"id":138695,"kind":"person","name":"MAROON JOSEPH C MD","position":1,"cik":"0001221600","reported_name":"MAROON JOSEPH C MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-03-07T19:17:44.000Z","date":"2017-03-03","kind":"grant","acquired":true,"shares":3653,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit (RSU) represents the right to receive one ordinary share of Mylan N.V. These RSUs will vest in full on March 3, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit (RSU) represents the right to receive one ordinary share of Mylan N.V. These RSUs will vest in full on March 3, 2018."}],"balance_after":3653,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":3653},"source":{"system":"sec-edgar","filing":"0000899243-17-006737","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1221600/000089924317006737/doc4.xml","form_type":"4"}},{"id":4396985,"issuer":{"id":16217,"kind":"organization","name":"Mylan II B.V.","symbol":"MYL"},"owners":[{"id":138695,"kind":"person","name":"MAROON JOSEPH C MD","position":1,"cik":"0001221600","reported_name":"MAROON JOSEPH C MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Stock Option - Right to Buy","published_at":"2017-03-07T19:17:44.000Z","date":"2017-03-03","kind":"grant","acquired":true,"shares":2928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options will vest in full on March 3, 2018 and expire on March 3, 2027."}],"balance_after":2928,"derivative":{"exercise_price":45.18,"expiration_date":"2027-03-03","underlying":"Ordinary Shares","underlying_shares":2928},"source":{"system":"sec-edgar","filing":"0000899243-17-006737","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1221600/000089924317006737/doc4.xml","form_type":"4"}},{"id":4435677,"issuer":{"id":16217,"kind":"organization","name":"Mylan II B.V.","symbol":"MYL"},"owners":[{"id":138695,"kind":"person","name":"MAROON JOSEPH C MD","position":1,"cik":"0001221600","reported_name":"MAROON JOSEPH C MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-02-21T19:03:55.000Z","date":"2017-02-17","kind":"exercise","acquired":false,"shares":3567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive one ordinary share of Mylan N.V. These RSUs vested in full on February 17, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive one ordinary share of Mylan N.V. These RSUs vested in full on February 17, 2017."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":3567},"source":{"system":"sec-edgar","filing":"0000899243-17-004827","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1221600/000089924317004827/doc4.xml","form_type":"4"}},{"id":4435676,"issuer":{"id":16217,"kind":"organization","name":"Mylan II B.V.","symbol":"MYL"},"owners":[{"id":138695,"kind":"person","name":"MAROON JOSEPH C MD","position":1,"cik":"0001221600","reported_name":"MAROON JOSEPH C MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-02-21T19:03:55.000Z","date":"2017-02-17","kind":"exercise","acquired":true,"shares":3567,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25603,"source":{"system":"sec-edgar","filing":"0000899243-17-004827","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1221600/000089924317004827/doc4.xml","form_type":"4"}}]}